Chemotherapy Infusion Pumps Market: Increase in the Incidence and Prevalence of Cancer to Drive the Market

2021-04-09

Chemotherapy is a process that uses drugs for the control, cure, and palliation of cancer. Cancer, in its early stages, can be cured and controlled using chemotherapy. Also, chemotherapy is used to ease the symptoms caused by cancer in the later stages. Chemotherapy pumps or chemotherapy infusion pumps help in the administration of chemotherapy drugs in a controlled manner. Read Report Overview - The chemotherapy infusion pump is made up of a hard plastic bottle, and inside the plastic bottle, there is a balloon that holds the chemotherapy drug. The balloon pushes the chemo in the patient’s body, and the flow restrictor (outside the balloon) helps in restricting the flow of the chemo. Cancer is one of the leading causes of death globally after cardiovascular diseases. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. An increase in the cancer-afflicted population is anticipated to be a key driver of the chemotherapy infusion pumps market. Request Brochure of Report - According to a Centers for Disease Control and Prevention (CDC) report in 2014, the number of cancer patients diagnosed in the U.S. reached approximately 21 million. It is also expected that this number would reach 25.4 million by the end of 2024. Over 60% of the world’s new cancer cases occur in Asia, Africa, and South America. Nearly the same percentage of cancer deaths also take place in these regions. Stomach, liver, lung, breast, and esophageal cancer are most prevalent among populations worldwide. The global chemotherapy infusion pumps market is primarily driven by an increase in the incidence and prevalence of cancer. In addition, increase in the adoption of chemotherapy infusion pumps for the delivery of chemo medicines, increase in the geriatric population, advancements in health care are expected to boost the growth of the global chemotherapy infusion pumps market in the next few years. Request for Custom Research - Furthermore, existing market players are deploying advanced techniques and strategies to come up with novel ways for manufacturing technologically enhanced infusion pumps. This is likely to propel demand for infusion pumps for chemotherapy during the forecast period. However, frequent product recalls and stringent government regulations are expected to restrain the market in the coming years. The global chemotherapy infusion pumps market can be segmented based on type, end-user, and region. Based on type, the market can be divided into large volume pump (LVP), elastomeric pump, and syringe pump. Based on end-user, the market can be divided into home care, hospitals, and clinics. Request for Analysis of COVID-19 Impact on Chemotherapy Infusion Pumps Market - In terms of region, the global chemotherapy infusion pumps market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a dominant share of the market in 2017, due to the high rate of adoption of chemotherapy infusion pumps in the region. Also, a rise in prevalence of cancer and presence of a large number of manufacturers in North America are expected to boost the chemotherapy infusion pumps market during the forecast period. Asia Pacific and Latin America are expected to be highly lucrative regions of the chemotherapy infusion pumps market in the near future. The market in these regions is projected to expand rapidly during the forecast period, owing to a large population base, increase in the number of hospitals, and rise in the adoption of infusion pumps for chemotherapy. Pre Book Chemotherapy Infusion Pumps Market Report at Key players operating in the global chemotherapy infusion pumps market include ICU Medical, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Halyard Health, Inc., Baxter, Fresenius SE & Co. KGaA, Smiths Group plc., Moog Inc., ZynoMed, and Micrel Medical Devices SA. Browse more Reports by Transparency Market Research: Meningococcal Infections Treatment Market: Liquid Chromatography Market: Chagas Disease Treatment Market: About Us Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision. Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website:

机构